Detailed reports from four working session and a workshop on preclinical models in personalized medicine. The working sessions were dedicated to 1. Industry, 2. In silico models, 3. In vivo models and 4. In vitro models. The main workshop discussed the outline of recommendations for robust and reproducible preclinical research in personalised medicine.
Vibeke Fosse, Emanuela Oldoni, Florence Biétrix, Alfredo Budillon, Evangelos P. Daskalopoulos, Maddalena Fratelli, Björn Gerlach, Peter Groenen, Sabine M. Hölter, Julia M. L. Menon, Ali Mobasheri, Nikki Osborne, Merel Ritskes‐Hoitinga, Bettina Ryll, Elmar Schmitt, Anton Ussi, Antoni L. Andreu, Emmet McCormack, Rita Banzi, Jacques Demotes‐Mainard, Paula Garcia, Chiara Gerardi, Enrico Glaab, Josep María Haro, Frank Hulstaert, Lorena San Miguel, Judit Subirana Mirete, Albert Sánchez‐Niubò, Raphaël Porcher, Armin Rauschenberger, M. Rodriguez, Cecilia Superchi,
Sara Cherry, Hans Clevers, Mindy I. Davis, Simon G. P. Funnell, Lee Gehrke, Linda G. Griffith, Abigail C Grossman, Thomas Härtung, Donald E. Ingber, Nicole Kleinstreuer, Calvin J. Kuo, Emily M. Lee, Christine L. Mummery, Thames Pickett, Sasirekha Ramani, Edwin A. Rosado-Olivieri, Evi Struble, Zhengpeng Wan, Mark S. Williams, Matthew D. Hall, Marc Ferrer, Sarine Markossian, Robert Jordan, ,
Donald M. McDonald, Beverly A. Teicher, William G. Stetler‐Stevenson, Sylvia S. W. Ng, William D. Figg, Judah Folkman, Douglas Hanahan, Robert Auerbach, Michael S. O’Reilly, Roy S. Herbst, David A. Cheresh, Michael S. Gordon, Alexander Eggermont, Steven K. Libutti
Discussion(0)
No comments yet. Be the first to comment.